叶下珠抗肝纤维化机制的作用研究进展  

The Study Progress of Phyllanthus Urinaria Anti-hepatic Fibrosis

作　　者：杨浩然 沈志强 YANG Hao-ran;SHEN Zhi-qiang(College of Pharmaceutical Science & Yunnan Key Laboratory of Pharmacology for Natural Products,Kunming Medical University,Kunming 650500,China)

机构地区：[1]昆明医科大学药学院暨云南省天然药物药理重点实验室

出　　处：《江西中医药大学学报》2019年第3期111-114,共4页Journal of Jiangxi University of Chinese Medicine

基　　金：国家自然科学基金项目(8156130093)

摘　　要：叶下珠是分布于我国南方地区广泛应用于临床的一种传统中草药,近年来国内外对叶下珠及其复方制剂抗肝纤维化作用实验研究有较多报道。肝纤维化是肝硬化的前期阶段,肝硬化是不可逆转的严重的肝脏病变,但现代研究说明肝纤维化也是可以逆转的。本文就叶下珠及其复方制剂抗肝纤维化的作用机制文献进行整理和分类,为相关研究提供借鉴。Phyllanthus urinaria is a kind of traditional Chinese medicine in China,widely distributed in southern China.In recent years at home and abroad,Phyllanthus urinaria and its compound preparation of anti liver fibrosis experimental research were reported.Liver fibrosis is the early stage of cirrhosis,which is a serious and irreversible disease of the liver,but modern studies have shown that liver fibrosis is reversible.The mechanism of the Phyllanthus urinaria and its compound anti hepatic fibrosis by sorting and classification can provide the reference for the related research.

关 键 词：抗肝纤维化 叶下珠 作用机制 

分 类 号：R285[医药卫生—中药学]